Minimal sex-differential modulation of reactivity to pathogens and toll-like receptor ligands following infant Bacillus Calmette–Guérin Russia vaccination
Bacillus Calmette–Guérin (BCG), the only licensed vaccine against tuberculosis, has been shown to provide heterologous protection against unrelated pathogens and enhance antibody responses to several routine expanded program on immunization (EPI) vaccines. Understanding these heterologous effects is...
Principais autores: | Darboe, F, Adetifa, JU, Reynolds, J, Hossin, S, Plebanski, M, Netea, MG, Rowland-Jones, SL, Sutherland, JS, Flanagan, KL |
---|---|
Formato: | Journal article |
Publicado em: |
Frontiers Media
2017
|
Registros relacionados
-
Minimal Sex-Differential Modulation of Reactivity to Pathogens and Toll-Like Receptor Ligands following Infant Bacillus Calmette–Guérin Russia Vaccination
por: Fatoumatta Darboe, et al.
Publicado em: (2017-09-01) -
Reiter's syndrome postintravesical Bacillus Calmette–Guérin instillations
por: Ng, K.L., et al.
Publicado em: (2017) -
Bacillus Calmette–Guérin Immunotherapy for Cancer
por: Fabíola Cardillo, et al.
Publicado em: (2021-05-01) -
Bacillus Calmette–Guérin and Bladder Cancer
por: Azad H.A. Razack
Publicado em: (2007-10-01) -
Hepatitis in Disseminated Bacillus Calmette-Guérin Infection
por: Markus U Göttke, et al.
Publicado em: (2000-01-01)